Compared to NK specimens, A9 mRNA levels were about 6-fold upregulated in ccRCC tumors; the increase in non-ccRCC tumors (papillary, chromophobe, collecting duct, and sarcomatoid), was ~3-fold (Fig. 2a). This evidence concerns the gene IGKV1D-22 and nonpapillary renal cell carcinoma.